COGT Cogent Biosciences, Inc. logo

COGT Cogent Biosciences, Inc.

Healthcare
$33.55+0.00%OpenMarket Cap: $5.73B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

2

Dispositions

1

Buy/Sell Ratio

2.00

Net Shares

+686

Shares Acquired

160,686

Shares Disposed

160,000

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 21Robbins Andrew Rdirector, officer: President and CEOSell160,000$0.00497,503
Fri Apr 03Ferrante Karen JeandirectorSell686$35.24686
Tue Mar 31Fairmount Funds Management LLCdirectorSell7,000,000$34.665,503,418
Tue Mar 31Fairmount Funds Management LLCdirectorSell7,000,000$0.0012,503,418
Tue Mar 31Fairmount Funds Management LLCdirectorSell28,000$0.0039,414
Thu Jan 22Fairmount Funds Management LLCdirectorSell3,500,000$36.405,503,418
Mon Jan 05Ferrante Karen JeandirectorSell643$34.74643
Tue Dec 30Sachs Jessicaofficer: Chief Medical OfficerSell82,642$38.70133,938
Tue Dec 30Robinson John Edwardofficer: Chief Scientific OfficerSell90,000$38.74140,002
Tue Dec 30Kearns Evanofficer: Chief Legal OfficerSell65,000$38.70109,398
Tue Dec 30Green John L.officer: Chief Financial OfficerSell77,000$38.68131,834
Fri Dec 19Robinson John Edwardofficer: Chief Scientific OfficerSell139,998$39.45230,002
Fri Dec 19Robinson John Edwardofficer: Chief Scientific OfficerSell320,000$0.00370,000
Fri Dec 19Robinson John Edwardofficer: Chief Scientific OfficerSell65,000$39.4565,000
Fri Dec 19Robinson John Edwardofficer: Chief Scientific OfficerSell50,000$0.0050,000